U.S. Cold And Flu Supplements Market Size & Outlook
U.S. cold and flu supplements market, 2017-2030 (US$M)
Related Markets
U.S. cold and flu supplements market highlights
- The U.S. cold and flu supplements market generated a revenue of USD 4,398.9 million in 2022 and is expected to reach USD 9,977.4 million by 2030.
- The U.S. market is expected to grow at a CAGR of 10.8% from 2023 to 2030.
- In terms of segment, vitamins & minerals was the largest revenue generating product in 2022.
- Herbal Extracts is the most lucrative product segment registering the fastest growth during the forecast period.
Cold and flu supplements market data book summary
| Market revenue in 2022 | USD 4,398.9 million |
| Market revenue in 2030 | USD 9,977.4 million |
| Growth rate | 10.8% (CAGR from 2022 to 2030) |
| Largest segment | Vitamins & minerals |
| Fastest growing segment | Herbal Extracts |
| Historical data | 2017 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Vitamins & Minerals, Herbal Extracts, Natural Molecules |
| Key market players worldwide | Amway Malaysia Holdings, Klaire Labs, Nordic Naturals, Himalaya Wellness, Nu Skin Enterprises Inc Class A, Pfizer Inc, NOW Foods, Natures Sunshine Products Inc, Wakunaga Pharmaceutical, Neurobiologix Supplements, Parkway Products, Vitamin Shoppe |
Other key industry trends
- In terms of revenue, U.S. accounted for 28.8% of the global cold and flu supplements market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. cold and flu supplements market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 9,977.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cold And Flu Supplements Market Scope
Cold And Flu Supplements Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. cold and flu supplements market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cold and flu supplements market will help companies and investors design strategic landscapes.
Vitamins & minerals was the largest segment with a revenue share of 40.03% in 2022. Horizon Databook has segmented the U.S. cold and flu supplements market based on vitamins & minerals, herbal extracts, natural molecules covering the revenue growth of each sub-segment from 2017 to 2030.
In the U.S., seasonal influenza (flu) viruses are typically observed to circulate during the fall and winter months, constituting what is commonly referred to as the flu season. The flu activity commences its ascent in October, and the timing and duration of each flu season can vary.
Generally, the highest levels of flu activity are recorded between December and February, although noteworthy activity can persist until May. However, since the onset of the COVID pandemic, the predictability of flu activity's timing and duration has been diminished.
The timeline of peak flu activity in the U.S., from the flu season of 1982–1983 through the flu season of 2021–2022, is illustrated in the graph below. The "peak month of flu activity" refers to the month during a specific flu season.
Reasons to subscribe to U.S. cold and flu supplements market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. cold and flu supplements market databook
-
Our clientele includes a mix of cold and flu supplements market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. cold and flu supplements market , including forecasts for subscribers. This country databook contains high-level insights into U.S. cold and flu supplements market from 2017 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. cold and flu supplements market size, by product, 2017-2030 (US$M)
U.S. Cold And Flu Supplements Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
